In addition to the compounds mentioned above, the LncRNA (long non-coding RNA) SRA (steroid receptor RNA activator) can also promote hepatic steatosis by downregulating FOXO1 expression and inhibiting ATGL transcription (75). The gene discussed is FOXO1; the disease is fatty liver disease.